Teneligliptin, a DPP-4 Inhibitor, Improves Vascular Endothelial Function via Divergent Actions Including Changes in Circulating Endothelial Progenitor Cells.

Diabetes Metab Syndr Obes · 2023 · PMC10108873 · PMID 37077576

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

did not reach statistical significanceno p-value reported

The number of EPCs showed an increasing trend in the teneligliptin treated group; albeit this did not reach statistical significance.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.